Silent proteinuria and kidney disease: The importance of ACR testing for early detection
In a crucial medical warning highlighting the "silent killers" within the human body, Dr. Shadi Khaled Amr, a consultant in internal medicine and nephrology, cautioned against relying solely on routine urine test results as the only way to assess kidney health. He emphasized that kidney diseases are insidious, often developing silently and silently, without leaving a clear trace in standard initial tests. This necessitates a shift in screening strategies to ensure the early detection of any functional impairment.
The numbers reveal the truth
Dr. Amr explained, using precise figures, that the normal level of protein in urine should not exceed 150 mg per day, while the level of albumin—the most important and sensitive protein—should remain below 30 mg per day. He pointed out that any increase in albumin levels above this limit, even if slight, is an early warning sign and a clear indication of the beginning of kidney damage, even in the presence of "normal" results in a standard urine test. This presents both the patient and the doctor with the challenge of accurate diagnosis.
Why is it called the silent disease?
Physiologically, healthy kidneys act as a delicate and complex filter, purifying the blood of toxins and waste products while retaining vital elements like proteins within the bloodstream. When the kidneys begin to lose their efficiency, very small amounts of albumin (microalbuminuria) leak out, which routine tests often fail to detect. This is where the danger lies: the patient may feel a false sense of security based on a "negative" test result, while the disease has already begun to slowly erode kidney tissue, progressing to advanced stages that may become difficult to treat later.
The shortcomings of traditional testing and the importance of ACR testing
The consultant in internal medicine and nephrology emphasized that standard urine tests using dipsticks lack the necessary sensitivity in the early stages and only produce positive results after kidney damage has progressed to advanced stages. In contrast, the albumin-to-creatinine ratio (ACR) test stands out as a crucial diagnostic tool due to its superior ability to detect even the smallest changes and identify the disease in its early stages, before clinical symptoms appear.
Most vulnerable groups
These tests are particularly important for specific patient groups. Dr. Shadi noted that elevated albumin levels with normal protein levels are a common scenario among patients with diabetes, chronic hypertension, morbid obesity, heart disease, and kidney transplants. These groups represent the largest segment of the population that should undergo regular and thorough testing protocols.
Other medical indications
In the context of medical explanation of cases of discrepancy in results, Dr. Amr explained that the presence of high protein with normal albumin may indicate a defect in the kidney tubules (“Tubular Dysfunction”), which may result from the side effects of some drugs, kidney infections, or blood diseases such as myeloma.
He concluded his remarks with a firm recommendation that at-risk patients should request periodic ACR testing and not rely solely on traditional testing, to ensure early medical intervention and protect the kidneys from reaching the stage of organ failure.
